Clinical Trial Update: Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating corticosteroids to prevent or treat hand-foot-skin reactions caused by pegylated liposomal doxorubicin in breast cancer is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING